Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Diabetes, Gestational | 6 | 2020 | 426 | 1.91 | Why? |
| Hyperglycemia | 5 | 2021 | 1363 | 1.30 | Why? |
| Blood Glucose | 6 | 2021 | 3642 | 1.22 | Why? |
| Fasting | 3 | 2021 | 555 | 1.21 | Why? |
| Glucose Tolerance Test | 5 | 2021 | 238 | 0.92 | Why? |
| Glycated Hemoglobin A | 6 | 2021 | 1316 | 0.86 | Why? |
| Pericardium | 1 | 2021 | 228 | 0.75 | Why? |
| Ovulation Induction | 1 | 2017 | 58 | 0.68 | Why? |
| Adipose Tissue | 1 | 2021 | 612 | 0.61 | Why? |
| Hypertension, Pregnancy-Induced | 1 | 2017 | 208 | 0.58 | Why? |
| Pregnancy Complications | 2 | 2021 | 1388 | 0.48 | Why? |
| Diabetes Mellitus | 9 | 2021 | 8207 | 0.48 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.46 | Why? |
| Blood Glucose Self-Monitoring | 1 | 2017 | 791 | 0.45 | Why? |
| Malnutrition | 1 | 2020 | 932 | 0.43 | Why? |
| Prenatal Diagnosis | 1 | 2014 | 345 | 0.43 | Why? |
| Nutritional Status | 1 | 2020 | 1403 | 0.41 | Why? |
| Pregnancy Outcome | 3 | 2017 | 3803 | 0.40 | Why? |
| Patient Compliance | 1 | 2017 | 1468 | 0.33 | Why? |
| Bariatric Surgery | 1 | 2017 | 1298 | 0.32 | Why? |
| Pregnancy | 9 | 2021 | 23879 | 0.31 | Why? |
| Perioperative Care | 3 | 2018 | 1329 | 0.25 | Why? |
| Body Mass Index | 3 | 2020 | 4306 | 0.22 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.20 | Why? |
| France | 7 | 2021 | 12074 | 0.19 | Why? |
| Prognosis | 8 | 2021 | 32490 | 0.19 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.19 | Why? |
| Multiple Endocrine Neoplasia Type 1 | 1 | 2018 | 10 | 0.18 | Why? |
| Insulin Detemir | 1 | 2017 | 10 | 0.18 | Why? |
| Insulin Aspart | 1 | 2017 | 4 | 0.18 | Why? |
| Bronchial Neoplasms | 1 | 2018 | 18 | 0.18 | Why? |
| Intraoperative Period | 1 | 2018 | 97 | 0.18 | Why? |
| Postprandial Period | 1 | 2017 | 45 | 0.18 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.16 | Why? |
| Nutrition Assessment | 1 | 2020 | 527 | 0.16 | Why? |
| Intraoperative Care | 1 | 2018 | 238 | 0.16 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2021 | 436 | 0.15 | Why? |
| Pregnancy Trimester, First | 1 | 2017 | 366 | 0.15 | Why? |
| Prediabetic State | 1 | 2017 | 200 | 0.14 | Why? |
| Weight Loss | 1 | 2020 | 826 | 0.14 | Why? |
| Neuroendocrine Tumors | 1 | 2018 | 241 | 0.14 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.14 | Why? |
| Hypoglycemic Agents | 3 | 2018 | 2165 | 0.14 | Why? |
| Diabetes Mellitus, Type 2 | 3 | 2021 | 6166 | 0.14 | Why? |
| Female | 19 | 2021 | 380317 | 0.13 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.13 | Why? |
| Microcirculation | 1 | 2017 | 447 | 0.13 | Why? |
| Sex Characteristics | 1 | 2021 | 1120 | 0.13 | Why? |
| Predictive Value of Tests | 2 | 2021 | 9537 | 0.12 | Why? |
| National Health Programs | 1 | 2018 | 807 | 0.11 | Why? |
| Geriatric Assessment | 1 | 2020 | 1372 | 0.11 | Why? |
| Insulin | 2 | 2018 | 1316 | 0.11 | Why? |
| Adult | 13 | 2021 | 244371 | 0.11 | Why? |
| Metformin | 1 | 2017 | 640 | 0.10 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.10 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.09 | Why? |
| Humans | 25 | 2021 | 930598 | 0.09 | Why? |
| Hypoglycemia | 1 | 2012 | 406 | 0.09 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.09 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.08 | Why? |
| Endothelium, Vascular | 1 | 2017 | 1751 | 0.08 | Why? |
| Skin | 1 | 2017 | 2096 | 0.07 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.07 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.07 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Aged | 9 | 2021 | 215776 | 0.06 | Why? |
| Male | 11 | 2021 | 367725 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.06 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.06 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.06 | Why? |
| Hyperplasia | 1 | 2021 | 204 | 0.06 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.05 | Why? |
| Physicians | 2 | 2018 | 4214 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.05 | Why? |
| Iontophoresis | 1 | 2017 | 8 | 0.05 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.05 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.05 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.04 | Why? |
| Administration, Cutaneous | 1 | 2017 | 229 | 0.04 | Why? |
| Regional Blood Flow | 1 | 2017 | 172 | 0.04 | Why? |
| Europe | 1 | 2014 | 12702 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Young Adult | 2 | 2017 | 93724 | 0.03 | Why? |
| Inpatients | 2 | 2021 | 5161 | 0.03 | Why? |
| Prospective Studies | 2 | 2017 | 43301 | 0.03 | Why? |
| Vasodilator Agents | 1 | 2017 | 344 | 0.03 | Why? |
| Mass Screening | 1 | 2014 | 8005 | 0.03 | Why? |
| Ambulatory Surgical Procedures | 1 | 2018 | 444 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Diabetes Complications | 1 | 2021 | 2358 | 0.02 | Why? |
| Professional Role | 1 | 2018 | 1280 | 0.02 | Why? |
| Anxiety | 1 | 2012 | 17311 | 0.02 | Why? |
| Educational Status | 1 | 2012 | 1451 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.02 | Why? |
| Cognition | 1 | 2012 | 1394 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.02 | Why? |
| Patient Education as Topic | 1 | 2012 | 1476 | 0.02 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Emotions | 1 | 2012 | 2418 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2012 | 1969 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Quality of Life | 1 | 2012 | 9820 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Depression | 1 | 2012 | 14116 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2012 | 43792 | 0.00 | Why? |
| Cross-Sectional Studies | 1 | 2012 | 53120 | 0.00 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
Cosson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(127)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_